EUVIMEDSkopri EUVIMED
CrossrefKarta ta’ informazzjoni

COPD: new treatment strategies

Patrick Mallia, Sebastian L Johnston

Future Prescriber · 2013

DOI: 10.1002/fps.104 ↗
AstrattDettalji biblijografiċi

Astratt

Abstract Chronic obstructive pulmonary disease (COPD) is a major public health problem that is projected to be the third leading cause of mortality by 2030. The most common aetiological factor related to the development of COPD is tobacco smoking, but exposure to burning biomass and outdoor air pollution are also major risk factors. The prevalence of COPD is projected to increase due to continued exposure to these risk factors and the aging of the world's population. The molecular mechanisms underlying the pathogenesis of COPD are complex and poorly understood and this has hampered the development of new therapies. Copyright © 2013 John Wiley & Sons, Ltd.

Għarfien li jaqbel max-xogħol tiegħek.

Minn bidu b’xejn u riċerka personali tal-letteratura sal-Research Suite sħiħa.

Ara t-tariffi →

Il-full texts kollha tal-pubblikaturi huma inklużi?

Le. Ir-referenzi biblijografiċi, l-astratti u t-testi sħaħ huma kontenuti differenti. Jekk test sħiħ huwiex disponibbli jiddependi mis-sors, Open Access u l-liċenzji eżistenti tiegħek. Pjan ta’ EUVIMED ma jissostitwix drittijiet addizzjonali tal-pubblikaturi.

Ara t-tariffi →